Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.2B | 3.8B | 4.1B | 4.4B |
Cost of revenue | 2.2B | 2.3B | 2.2B | 2.3B |
Gross profit | 2.0B | 1.5B | 1.9B | 2.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 83.3M | -75.3M | 84.4M | 85.8M |
Other operating expenses | — | — | — | 12.8M |
Operating income | 1.9B | 1.4B | 1.8B | 2.0B |
Non operating interest income | ||||
Income | 105.1M | 99.0M | 113.1M | 100.4M |
Expense | 148.6M | 145.7M | 139.3M | 145.3M |
Other income expense | — | — | — | — |
Pretax income | 1.9B | 1.3B | 1.8B | 1.9B |
Tax provision | 602.6M | 425.9M | 851.6M | 632.8M |
Net income | 1.3B | 872.9M | 953.5M | 1.3B |
Basic EPS | 0.1 | — | 0.1 | 0.1 |
Diluted EPS | 0.1 | — | 0.1 | 0.1 |
Basic average shares | 7.8B | — | 7.5B | 7.8B |
Diluted average shares | 7.8B | — | 7.5B | 7.8B |
EBITDA | 2.3B | 1.9B | 2.3B | 2.4B |
Net income from continuing op. | 1.3B | 3.3B | 953.5M | 1.3B |
Minority interests | -178.9M | -128.6M | -133.4M | -1.1B |
Preferred stock dividends | 0 | 0 | 0 | 0 |